CGENCompugen Ltd.

$202M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-10.7% YoY

Gross Profit

-$116,000-5.1% margin

Operating Income

-$8M-367.6% margin

Net Income

-$7M-314.4% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+55.3%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$115M

Total Liabilities

$58M

Stockholders' Equity

$57M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-10.7%
Gross Profit	-$116,000	$457,000	-125.4%
Operating Income	-$8M	-$8M	+1.1%
Net Income	-$7M	-$7M	+1.2%

CGEN Q1 2025 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena